nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS1—Ifosfamide—testicular cancer	0.222	0.311	CbGbCtD
Oxaprozin—PTGS2—Cisplatin—testicular cancer	0.128	0.179	CbGbCtD
Oxaprozin—PTGS2—Etoposide—testicular cancer	0.125	0.176	CbGbCtD
Oxaprozin—PTGS1—Etoposide—testicular cancer	0.106	0.149	CbGbCtD
Oxaprozin—CYP2C9—Ifosfamide—testicular cancer	0.0893	0.125	CbGbCtD
Oxaprozin—CYP2C9—Cisplatin—testicular cancer	0.0434	0.0608	CbGbCtD
Oxaprozin—Paraesthesia—Cisplatin—testicular cancer	0.000321	0.00112	CcSEcCtD
Oxaprozin—Thrombocytopenia—Etoposide—testicular cancer	0.000321	0.00112	CcSEcCtD
Oxaprozin—Tachycardia—Etoposide—testicular cancer	0.00032	0.00112	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—testicular cancer	0.00032	0.00112	CcSEcCtD
Oxaprozin—Dyspnoea—Cisplatin—testicular cancer	0.000319	0.00111	CcSEcCtD
Oxaprozin—Hyperhidrosis—Etoposide—testicular cancer	0.000317	0.00111	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—testicular cancer	0.000317	0.00111	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—testicular cancer	0.000316	0.0011	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—testicular cancer	0.000315	0.0011	CcSEcCtD
Oxaprozin—Anorexia—Etoposide—testicular cancer	0.000312	0.00109	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000311	0.00109	CcSEcCtD
Oxaprozin—Decreased appetite—Cisplatin—testicular cancer	0.000311	0.00109	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—testicular cancer	0.00031	0.00108	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—testicular cancer	0.000309	0.00108	CcSEcCtD
Oxaprozin—Vomiting—Bleomycin—testicular cancer	0.000309	0.00108	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—testicular cancer	0.000308	0.00107	CcSEcCtD
Oxaprozin—Pancytopenia—Epirubicin—testicular cancer	0.000307	0.00107	CcSEcCtD
Oxaprozin—Hypotension—Etoposide—testicular cancer	0.000306	0.00107	CcSEcCtD
Oxaprozin—Rash—Bleomycin—testicular cancer	0.000306	0.00107	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—testicular cancer	0.000306	0.00107	CcSEcCtD
Oxaprozin—Dermatitis—Bleomycin—testicular cancer	0.000306	0.00107	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000305	0.00106	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—testicular cancer	0.000302	0.00106	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—testicular cancer	0.000302	0.00105	CcSEcCtD
Oxaprozin—Stomatitis—Methotrexate—testicular cancer	0.0003	0.00105	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—testicular cancer	0.000299	0.00104	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—testicular cancer	0.000299	0.00104	CcSEcCtD
Oxaprozin—Asthenia—Ifosfamide—testicular cancer	0.000298	0.00104	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—testicular cancer	0.000296	0.00103	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000295	0.00103	CcSEcCtD
Oxaprozin—Feeling abnormal—Cisplatin—testicular cancer	0.000295	0.00103	CcSEcCtD
Oxaprozin—Paraesthesia—Etoposide—testicular cancer	0.000294	0.00103	CcSEcCtD
Oxaprozin—Pruritus—Ifosfamide—testicular cancer	0.000293	0.00102	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—testicular cancer	0.000293	0.00102	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—testicular cancer	0.000293	0.00102	CcSEcCtD
Oxaprozin—Dyspnoea—Etoposide—testicular cancer	0.000292	0.00102	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—testicular cancer	0.000291	0.00102	CcSEcCtD
Oxaprozin—Somnolence—Etoposide—testicular cancer	0.000291	0.00102	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—testicular cancer	0.00029	0.00101	CcSEcCtD
Oxaprozin—Nausea—Bleomycin—testicular cancer	0.000288	0.00101	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—testicular cancer	0.000288	0.00101	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—testicular cancer	0.000288	0.001	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—testicular cancer	0.000287	0.001	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000285	0.000997	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—testicular cancer	0.000285	0.000996	CcSEcCtD
Oxaprozin—Decreased appetite—Etoposide—testicular cancer	0.000285	0.000994	CcSEcCtD
Oxaprozin—Diarrhoea—Ifosfamide—testicular cancer	0.000284	0.000991	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—testicular cancer	0.000284	0.000991	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—testicular cancer	0.000283	0.000988	CcSEcCtD
Oxaprozin—Body temperature increased—Cisplatin—testicular cancer	0.000283	0.000987	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—testicular cancer	0.000281	0.00098	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—testicular cancer	0.000281	0.00098	CcSEcCtD
Oxaprozin—Constipation—Etoposide—testicular cancer	0.00028	0.000978	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—testicular cancer	0.00028	0.000977	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—testicular cancer	0.000279	0.000975	CcSEcCtD
Oxaprozin—Haemoglobin—Methotrexate—testicular cancer	0.000278	0.000969	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—testicular cancer	0.000276	0.000964	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—testicular cancer	0.000276	0.000964	CcSEcCtD
Oxaprozin—Haematuria—Epirubicin—testicular cancer	0.000275	0.000958	CcSEcCtD
Oxaprozin—Dizziness—Ifosfamide—testicular cancer	0.000274	0.000958	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000273	0.000952	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—testicular cancer	0.00027	0.000943	CcSEcCtD
Oxaprozin—Feeling abnormal—Etoposide—testicular cancer	0.00027	0.000942	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—testicular cancer	0.00027	0.000941	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—testicular cancer	0.000269	0.000939	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—testicular cancer	0.000269	0.000938	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—testicular cancer	0.000268	0.000936	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Etoposide—testicular cancer	0.000268	0.000935	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—testicular cancer	0.000266	0.00093	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000264	0.000922	CcSEcCtD
Oxaprozin—Vomiting—Ifosfamide—testicular cancer	0.000264	0.000921	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—testicular cancer	0.000262	0.000914	CcSEcCtD
Oxaprozin—Rash—Ifosfamide—testicular cancer	0.000262	0.000913	CcSEcCtD
Oxaprozin—Dermatitis—Ifosfamide—testicular cancer	0.000261	0.000912	CcSEcCtD
Oxaprozin—Erythema multiforme—Methotrexate—testicular cancer	0.000261	0.000912	CcSEcCtD
Oxaprozin—Urticaria—Etoposide—testicular cancer	0.00026	0.000909	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—testicular cancer	0.00026	0.000907	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—testicular cancer	0.00026	0.000907	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—testicular cancer	0.00026	0.000907	CcSEcCtD
Oxaprozin—Abdominal pain—Etoposide—testicular cancer	0.000259	0.000904	CcSEcCtD
Oxaprozin—Body temperature increased—Etoposide—testicular cancer	0.000259	0.000904	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—testicular cancer	0.000259	0.000904	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—testicular cancer	0.000259	0.000902	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—testicular cancer	0.000259	0.000902	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—testicular cancer	0.000258	0.000899	CcSEcCtD
Oxaprozin—Asthenia—Cisplatin—testicular cancer	0.000257	0.000896	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—testicular cancer	0.000254	0.000887	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—testicular cancer	0.00025	0.000873	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—testicular cancer	0.000249	0.000868	CcSEcCtD
Oxaprozin—Nausea—Ifosfamide—testicular cancer	0.000246	0.00086	CcSEcCtD
Oxaprozin—Diarrhoea—Cisplatin—testicular cancer	0.000245	0.000854	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—testicular cancer	0.000244	0.000853	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—testicular cancer	0.000244	0.000852	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—testicular cancer	0.000241	0.000841	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—testicular cancer	0.00024	0.000839	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—testicular cancer	0.000239	0.000835	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—testicular cancer	0.000239	0.000835	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—testicular cancer	0.000235	0.000822	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—testicular cancer	0.000235	0.000821	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—testicular cancer	0.000232	0.000809	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—testicular cancer	0.000231	0.000806	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—testicular cancer	0.000228	0.000797	CcSEcCtD
Oxaprozin—Vomiting—Cisplatin—testicular cancer	0.000227	0.000794	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—testicular cancer	0.000227	0.000791	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—testicular cancer	0.000226	0.000789	CcSEcCtD
Oxaprozin—Rash—Cisplatin—testicular cancer	0.000225	0.000787	CcSEcCtD
Oxaprozin—Dermatitis—Cisplatin—testicular cancer	0.000225	0.000786	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—testicular cancer	0.000224	0.000783	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—testicular cancer	0.000223	0.000779	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—testicular cancer	0.000223	0.000778	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—testicular cancer	0.000222	0.000776	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—testicular cancer	0.000222	0.000774	CcSEcCtD
Oxaprozin—Tension—Epirubicin—testicular cancer	0.000221	0.000771	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—testicular cancer	0.00022	0.000769	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—testicular cancer	0.000219	0.000763	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—testicular cancer	0.000217	0.000757	CcSEcCtD
Oxaprozin—Dizziness—Etoposide—testicular cancer	0.000217	0.000756	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—testicular cancer	0.000216	0.000754	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—testicular cancer	0.000215	0.000751	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—testicular cancer	0.000214	0.000746	CcSEcCtD
Oxaprozin—Nausea—Cisplatin—testicular cancer	0.000212	0.000742	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—testicular cancer	0.000212	0.00074	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—testicular cancer	0.000211	0.000738	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—testicular cancer	0.000209	0.000729	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—testicular cancer	0.000208	0.000727	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—testicular cancer	0.000208	0.000727	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—testicular cancer	0.000208	0.000726	CcSEcCtD
Oxaprozin—Rash—Etoposide—testicular cancer	0.000207	0.000721	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—testicular cancer	0.000206	0.00072	CcSEcCtD
Oxaprozin—Headache—Etoposide—testicular cancer	0.000205	0.000717	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—testicular cancer	0.000205	0.000716	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—testicular cancer	0.000204	0.000713	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—testicular cancer	0.000204	0.000712	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—testicular cancer	0.000203	0.000708	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—testicular cancer	0.000202	0.000706	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—testicular cancer	0.000202	0.000706	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—testicular cancer	0.000202	0.000706	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—testicular cancer	0.000202	0.000704	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—testicular cancer	0.000201	0.000703	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—testicular cancer	0.000199	0.000694	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—testicular cancer	0.000198	0.000691	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—testicular cancer	0.000198	0.00069	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—testicular cancer	0.000196	0.000685	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—testicular cancer	0.000196	0.000685	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—testicular cancer	0.000195	0.000681	CcSEcCtD
Oxaprozin—Infection—Methotrexate—testicular cancer	0.000195	0.000681	CcSEcCtD
Oxaprozin—Nausea—Etoposide—testicular cancer	0.000195	0.000679	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—testicular cancer	0.000194	0.000678	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000193	0.000674	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—testicular cancer	0.000192	0.000672	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—testicular cancer	0.000192	0.000671	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—testicular cancer	0.000191	0.000666	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—testicular cancer	0.00019	0.000662	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—testicular cancer	0.000189	0.000661	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—testicular cancer	0.000188	0.000655	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—testicular cancer	0.000187	0.000654	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—testicular cancer	0.000187	0.000653	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—testicular cancer	0.000187	0.000653	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—testicular cancer	0.000187	0.000652	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—testicular cancer	0.000186	0.000651	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—testicular cancer	0.000185	0.000646	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—testicular cancer	0.000184	0.000642	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—testicular cancer	0.000184	0.000641	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—testicular cancer	0.000184	0.000641	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—testicular cancer	0.000183	0.00064	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—testicular cancer	0.000183	0.000639	CcSEcCtD
Oxaprozin—Infection—Epirubicin—testicular cancer	0.000182	0.000637	CcSEcCtD
Oxaprozin—Shock—Epirubicin—testicular cancer	0.000181	0.000631	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—testicular cancer	0.00018	0.00063	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—testicular cancer	0.00018	0.000628	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—testicular cancer	0.00018	0.000628	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—testicular cancer	0.000179	0.000626	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—testicular cancer	0.000178	0.00062	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—testicular cancer	0.000178	0.00062	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—testicular cancer	0.000177	0.000617	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—testicular cancer	0.000176	0.000615	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—testicular cancer	0.000175	0.000611	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—testicular cancer	0.000175	0.000611	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—testicular cancer	0.000175	0.000611	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—testicular cancer	0.000174	0.000609	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—testicular cancer	0.000173	0.000605	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—testicular cancer	0.000173	0.000603	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—testicular cancer	0.000172	0.000599	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—testicular cancer	0.000171	0.000598	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—testicular cancer	0.000171	0.000596	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—testicular cancer	0.00017	0.000593	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—testicular cancer	0.00017	0.000593	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—testicular cancer	0.000169	0.000589	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—testicular cancer	0.000167	0.000584	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000166	0.000581	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—testicular cancer	0.000166	0.00058	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—testicular cancer	0.000166	0.000579	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—testicular cancer	0.000165	0.000576	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000164	0.000573	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—testicular cancer	0.000164	0.000572	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—testicular cancer	0.000163	0.00057	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—testicular cancer	0.000162	0.000565	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—testicular cancer	0.000162	0.000565	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—testicular cancer	0.000162	0.000564	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—testicular cancer	0.00016	0.00056	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—testicular cancer	0.00016	0.000557	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—testicular cancer	0.000159	0.000554	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—testicular cancer	0.000157	0.000548	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—testicular cancer	0.000156	0.000544	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—testicular cancer	0.000155	0.000542	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—testicular cancer	0.000155	0.000542	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—testicular cancer	0.000154	0.000537	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—testicular cancer	0.000153	0.000533	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—testicular cancer	0.000152	0.000529	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—testicular cancer	0.000151	0.000528	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—testicular cancer	0.000151	0.000527	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—testicular cancer	0.00015	0.000524	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—testicular cancer	0.00015	0.000522	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—testicular cancer	0.000148	0.000516	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—testicular cancer	0.000146	0.000509	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—testicular cancer	0.000145	0.000507	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—testicular cancer	0.000145	0.000507	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—testicular cancer	0.000145	0.000507	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—testicular cancer	0.000141	0.000492	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—testicular cancer	0.00014	0.000489	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000139	0.000485	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—testicular cancer	0.000139	0.000485	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—testicular cancer	0.000135	0.000471	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—testicular cancer	0.000134	0.000469	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—testicular cancer	0.000134	0.000469	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—testicular cancer	0.000134	0.000469	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—testicular cancer	0.000132	0.00046	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—testicular cancer	0.00013	0.000454	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—testicular cancer	0.00013	0.000453	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—testicular cancer	0.000126	0.000439	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—testicular cancer	0.000125	0.000436	CcSEcCtD
Oxaprozin—Rash—Methotrexate—testicular cancer	0.000124	0.000432	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—testicular cancer	0.000124	0.000432	CcSEcCtD
Oxaprozin—Headache—Methotrexate—testicular cancer	0.000123	0.000429	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—testicular cancer	0.000122	0.000426	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—testicular cancer	0.000121	0.000424	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—testicular cancer	0.00012	0.00042	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—testicular cancer	0.000117	0.000408	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—testicular cancer	0.000117	0.000407	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—testicular cancer	0.000116	0.000406	CcSEcCtD
Oxaprozin—Rash—Epirubicin—testicular cancer	0.000116	0.000404	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—testicular cancer	0.000116	0.000404	CcSEcCtD
Oxaprozin—Headache—Epirubicin—testicular cancer	0.000115	0.000402	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—testicular cancer	0.000112	0.000392	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—testicular cancer	0.000109	0.000381	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—testicular cancer	0.000108	0.000377	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—testicular cancer	0.000107	0.000374	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—testicular cancer	0.000107	0.000374	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—testicular cancer	0.000106	0.000372	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—testicular cancer	0.000101	0.000352	CcSEcCtD
